The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: A retrospective analysis from a randomized clinical trial

Respiratory Medicine

Volumn 108, Issue 1, 2014, Pages 189-194

  Judson, Marc A ^a   Baughman, Robert P ^b   Costabel, Ulrich ^c   Mack, Michael ^d   Barnathan, Elliot S ^d  

^a ALBANY MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Corticosteroids; Infliximab; Pulmonary; Sarcoidosis; Treatment

Indexed keywords

CORTICOSTEROID; CYTOTOXIC AGENT; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; PREDNISONE;

ADULT; ARTICLE; CORRELATION COEFFICIENT; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; FORCED VITAL CAPACITY; HUMAN; LUNG SARCOIDOSIS; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE;

CORTICOSTEROIDS; INFLIXIMAB; PULMONARY; SARCOIDOSIS; TREATMENT;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PREDNISONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY; TREATMENT OUTCOME;

EID: 84893690577     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.11.019     Document Type: Article

References (14)

1. R.P. Baughman, M. Drent, M. Kavuru, M.A. Judson, U. Costabel, and R. du Bois et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement Am J Respir Crit Care Med 174 7 2006 795 802
2. M.A. Judson, R.P. Baughman, U. Costabel, S. Flavin, K.H. Lo, and M.S. Kavuru et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial Eur Respir J 31 6 2008 1189 1196
3. H. Fehrenbach, G. Zissel, T. Goldmann, T. Tschernig, E. Vollmer, and R. Pabst et al. Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis Eur Respir J 21 3 2003 421 428
4. G. Zissel, and J. Muller-Quernheim Sarcoidosis: historical perspective and immunopathogenesis (part I) Respir Med 92 2 1998 126 139
5. M.C. Iannuzzi, B.A. Rybicki, and A.S. Teirstein Sarcoidosis N Engl J Med 357 21 2007 2153 2165
6. J.C. Grutters, and J.M. van den Bosch Corticosteroid treatment in sarcoidosis Eur Respir J 28 3 2006 627 636
7. G.W. Hunninghake, U. Costabel, M. Ando, R. Baughman, J.F. Cordier, and R. du Bois et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders Sarcoidosis Vasc Diffuse Lung Dis 16 2 1999 149 173
8. M.A. Judson The treatment of pulmonary sarcoidosis Respir Med 106 2012 1351 1361
9. S.H. Beegle, K. Barba, R. Gobunsuy, and M.A. Judson Current and emerging pharmacological treatments for sarcoidosis: a review Drug Des Devel Ther 7 2013 325 338
10. I.M. Adcock, and K. Ito Molecular mechanisms of corticosteroid actions Monaldi Arch Chest Dis 55 3 2000 256 266
11. M.F. Muers, W.G. Middleton, G.J. Gibson, R.J. Prescott, D.N. Mitchell, and C.K. Connolly et al. A simple radiographic scoring method for monitoring pulmonary sarcoidosis: relations between radiographic scores, dyspnoea grade and respiratory function in the British Thoracic Society Study of Long-Term Corticosteroid Treatment Sarcoidosis Vasc Diffuse Lung Dis 14 1 1997 46 56
12. B.P. McKinzie, W.M. Bullington, J.E. Mazur, and M.A. Judson Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations Am J Med Sci 339 1 2010 1 4
13. H.L. Israel, D.W. Fouts, and R.A. Beggs A controlled trial of prednisone treatment of sarcoidosis Am Rev Respir Dis 107 4 1973 609 614
14. E. Stagaki, W.K. Mountford, D.T. Lackland, and M.A. Judson The treatment of lupus pernio: results of 116 treatment courses in 54 patients Chest 135 2 2009 468 476